All announcements

Fourteen research projects will focus on antiviral research and drug development for henipaviruses, a subgroup of viruses with pandemic potential.

The PAD initiative sponsors ICAR

The ‘PAD Request for Proposals’ focused on Antivirals for Pandemic Influenza closed on 14 December 2022.

The focus of this PAD Request for Proposals (RfP) is novel antivirals for pandemic influenza. Pandemic influenza remains is a substantial threat to public health. There have been six major influenza epidemics with the 1918 flu pandemic being the most severe, leading to the deaths of 50–100 million people worldwide. There is a need for cheap and safe antiviral compounds that target viral/host proteins and pathways necessary for replication and pathogenesis that are clearly differentiated from currently marketed drugs for seasonal influenza.

The focus of the upcoming PAD Request for Proposals will be ‘Antivirals for Pandemic Influenza’.

The open ‘PAD Request for Proposals’ focused on Henipavirus has closed on May 5th, 2022.

99 proposals have been submitted from researchers from 91 different institutions/organizations from 28 countries spanning 6 continents.